Navigation Links
The Homeopathic Revolution
Date:10/18/2007

Why Famous People and Cultural Heroes Choose Homeopathy

By Dana Ullman, MPH

Foreword by Dr. Peter Fisher (Physician to Her Majesty the Queen)

SAN FRANCISCO, Oct. 18 /PRNewswire/ -- There is a good reason that 11 American presidents, 7 popes, Charles Darwin, J.D. Rockefeller, David Beckham, Tina Turner, and Mother Teresa have used and advocated for homeopathic treatment: homeopathy works!

The majority of people in Western society seek out conventional medical treatment, but an amazing and impressive number of cultural heroes and celebrities of the past 200 years have been treated with and raved about homeopathic medicine. Through a cutting-edge explanation of homeopathy as "nanopharmacology," Dana Ullman's Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy presents a strong case for this internationally respected, but often misunderstood, medical practice. (http://www.homeopathicrevolution.com)

Homeopathic medicine is presently the leading alternative medicine in Europe, and Ullman is one of the foremost experts in the field. With endorsements from Larry Dossey, MD (The Extraordinary Healing Power of Ordinary Things), John Robbins (Diet for a New America), C. Norman Shealy, MD, PhD (founding president of the American Holistic Medical Association), and professors at Harvard, Georgetown, and Stanford Schools of Medicine, it's clear that Ullman is highly respected by health professionals.

The Homeopathic Revolution uncovers a veritable treasure-trove of stories from cultural heroes of the past 200 years. Of special interest are the riveting anecdotes of literary greats, sports superstars, physicians, scientists, celebrities, musicians, artists, fashionistas, corporate leaders, philanthropists, clergy, spiritual leaders, and monarchs.

Dana Ullman, America's leading spokesperson for homeopathy, has a
'/>"/>

SOURCE Dana Ullman
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Homeopathic preparation better than placebo in perennial allergic
2. Researchers Question The Effectiveness Of Homeopathic Remedies
3. Doctors worried about Homeopathic licensing
4. Doctors in Scotland Prescribe Homeopathic or Herbal Remedies
5. A Homeopathic Cure for Cancer Under Trial in US
6. Hemopurifier may revolutionise AIDS treatment
7. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
8. Revolution in Genetics to Open Avenues for Treating Cancer
9. Revolution in surgery
10. Percutaneous aortic valve replacement- a revolution in Cardiac Surgery
11. Nanotechnology Revolution To Be Spearheaded By European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...are, a home medical services provider specializing...d DME services, is expanding. Two new pharmacies i...me infusion therapy and one in oral medication, a ... Clinton, NY (PRWEB) June 22, 2009 ...vider specializing in infusion, specialty medicati...
(Date:7/2/2009)...e-USNewswire/ -- Acetaminophen is an ingredient fo...cines to help relieve pain and reduce fever. Many...lenol and prescription brand names, Vicodin and Pe...met on June 30, 2009 to address liver related inju...ee voted 20-17 to urge the FDA to put a ban on Vic...
(Date:7/2/2009)... threat, expert says , , THURSDAY, July ...certain species of wildlife, which need to be prot..., "Cancer is one of the leading health concerns...f human deaths. But we now understand that cancer ...or Denise McAloose, chief pathologist for the Wild...
(Date:7/2/2009)...esday night saw the launch of (RED)ZONES at the fi...icked off their new tour to a rapturous sold out c...location areas directly adjacent to the stage whic...kets for the (RED)ZONES are available through auct...ing to the Global Fund to help fund AIDS programs ...
Breaking Medicine News(10 mins):Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Cancer Endangers Some Wildlife Species 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3
...far the leading cancers in the world today. The pr...ate and thus the treatment, which includes radiati...mount of tissue leading to disfigurement. Now two...ting with the American Dental Association (ADA) to...
... has revealed that two more people in China have s...lity figure to five in the country // . The lates...irl. The H5N1 virus is reported to be responsible ...ean that the human infection of bird flu is out of...
...dure used to stitch up the torn hymen in girls in ...rity in the United States // , for different reaso...he hymen - long considered the only positive proof...owing plastic surgery segments, the American Socie...
...l. Yan, PhD., M.P.H., of the Feinberg School of Me...ng University, China, and colleagues on the effect... illness and death. // The Chicago Heart Associat...ncluded 17,643 men and women. They were studied fr...
Other Medicine News:Health News:Obesity Increases The Risk Of Cardiovascular Diseases 2
(Date:6/26/2009)..."Agendia,s Breast Cancer Recurrence Test MammaPrin...sensus Recommendations" issued,on 23 Jun 2009 12:...e advised,that the subheadline was missing from t...ire. Complete, corrected release follows: , ...ncer Recurrence Test MammaPrint Included in,Inter...
(Date:6/26/2009)...ds Approval of New Anti-TNF Therapy in Three Rheum...r , , HORSHAM, Pa. and KENILWORTH, N.J., June 2... Inc. and Schering-Plough Corporation (NYSE: SGP...l Products for Human Use (CHMP) of the European Me...ecommending the approval of SIMPONI(TM) (golimumab...
(Date:6/25/2009)...wire-USNewswire/ -- As of mid-2009, The Michael J....dy funded over $1 million in high-risk, high-rewar...t through its groundbreaking Rapid Response Innov...the safety and efficacy of an FDA-approved drug fo...ation of a tenuous link between PD and certain str...
(Date:6/25/2009)...ent Covering ARIKACE for Once-Daily Treatment of P...N, N.J., June 25 Cystic Fibrosis F...te of the Cystic Fibrosis Foundation, has provided...ntinued development of ARIKACE(TM) (liposomal amik...reat Pseudomonas lung infections in cystic fibro...
Breaking Medicine Technology:/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 1Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 2Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 3Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 1Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 2Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 3Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 4XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 1XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 2XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 3LUMEDX Launches New Interventional Radiology Software 11091 1LUMEDX Launches New Interventional Radiology Software 11091 2
...wire/ -- Researchers from the,Barbara Ann Karmanos...evidence today that an antibiotic typically prescr...n eventually treating,certain types of cancers. , ...Karmanos, and,members of his lab announced the fin...nol (CQ) appears to have an anti-tumor effect,in m...
...urea derivative compound series show highly,sele...cancer,treatment , , QUBEC CITY, Canada, Ap...daq:,AEZS), a global, pure play biopharmaceutica...ogy, today presented an abstract,outlining first...,with high selectivity for PI3K inhibition, at the...
Other Medicine Technology:Alzheimer's Drug Shows Promise in Fighting Cancer 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 4
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Extra Security with porous tape.
Convenience, Protection, Comfort and Security -- FirstChoice pouches are your product of choice if you are looking for the convenience of a one-piece pouch that is either cut-to-fit or pre-cut to you
Inquire
Inquire
Medicine Products: